Pfizer on Tuesday said its profit in the third quarter tripled, mostly due to a huge charge depressing last year’s results.

The world’s largest drug maker by sales earned $2.3bn, or 34 cents per share, in the quarter, up from $761m, or 11 cents per share, a year ago.